H47.10 — Unspecified Papilledema

Overview

H47.10 is a valid, HIPAA-billable ICD-10-CM diagnosis code representing unspecified papilledema — swelling of the optic disc (optic nerve head) that has been identified on clinical examination or imaging, but for which the specific underlying etiology or mechanism has not yet been documented or determined at the time of coding. It falls under Chapter VII of ICD-10-CM, Diseases of the Eye and Adnexa, within the broader category of Other Disorders of the Optic Nerve and Visual Pathways (H47).

Papilledema in its truest clinical definition refers specifically to optic disc edema caused by elevated intracranial pressure (ICP); however, in common clinical and coding usage, the term is often applied more broadly to any disc swelling until the etiology is clarified. ICD-10-CM acknowledges this ambiguity by providing H47.10 for unspecified cases alongside more specific codes for papilledema associated with increased intracranial pressure (H47.11), decreased ocular pressure (H47.12), and retinal disorders (H47.13).

Papilledema is almost always a bilateral finding and is considered a neuro-ophthalmic emergency until proven otherwise. The key clinical distinction between papilledema and pseudopapilledema (H47.33x, often caused by optic disc drusen) has significant management implications and directly affects code selection.


Code Classification & Hierarchy

H00-H59   Diseases of the Eye and Adnexa
 └── H47      Other Disorders of Optic [2nd] Nerve and Visual Pathways
      └── H47.1    Papilledema (non-billable header)
           ├── H47.10   Unspecified Papilledema ✓  ← YOU ARE HERE
           ├── H47.11   Papilledema associated with increased intracranial pressure ✓
           ├── H47.12   Papilledema associated with decreased ocular pressure ✓
           ├── H47.13   Papilledema associated with retinal disorder ✓
           └── H47.14   Foster-Kennedy Syndrome (non-billable header)
                ├── H47.141   Foster-Kennedy syndrome, right eye ✓
                ├── H47.142   Foster-Kennedy syndrome, left eye ✓
                ├── H47.143   Foster-Kennedy syndrome, bilateral ✓
                └── H47.149   Foster-Kennedy syndrome, unspecified eye ✓

Note

H47.1 is a non-billable category header. H47.10 is the only code in this subcategory that does not require additional character specificity — it is billable at the 5-character level. H47.11, H47.12, and H47.13 are also billable at 5 characters without further laterality subdivision.


Full Code Tree — H47 Other Disorders of Optic Nerve and Visual Pathways

CodeDescriptionBillable
H47Other disorders of optic [2nd] nerve and visual pathwaysNo
H47.0Disorders of optic nerve, NECNo
H47.011-019Ischemic optic neuropathy (right/left/bilateral/unspecified)Yes
H47.021-029Hemorrhage in optic nerve sheath (right/left/bilateral/unspecified)Yes
H47.031-039Optic nerve hypoplasia (right/left/bilateral/unspecified)Yes
H47.091-099Other disorders of optic nerve, NEC (right/left/bilateral/unspecified)Yes
H47.1PapilledemaNo
H47.10Unspecified papilledemaYes ← Target Code
H47.11Papilledema assoc. with increased intracranial pressureYes
H47.12Papilledema assoc. with decreased ocular pressureYes
H47.13Papilledema assoc. with retinal disorderYes
H47.141-149Foster-Kennedy syndrome (right/left/bilateral/unspecified)Yes
H47.2Optic atrophyNo
H47.20Unspecified optic atrophyYes
H47.211-219Primary optic atrophyYes
H47.22Hereditary optic atrophyYes
H47.231-239Glaucomatous optic atrophyYes
H47.291-299Other optic atrophyYes
H47.3Other disorders of optic discNo
H47.311-319Coloboma of optic discYes
H47.321-329Drusen of optic discYes
H47.331-339Pseudopapilledema of optic discYes
H47.391-399Other disorders of optic discYes
H47.4Disorders of optic chiasmNo
H47.41Optic chiasm disorder due to inflammatory disordersYes
H47.42Optic chiasm disorder due to neoplasmYes
H47.43Optic chiasm disorder due to vascular disordersYes
H47.49Optic chiasm disorder due to other disordersYes
H47.5Disorders of other visual pathwaysNo
H47.511-519Visual pathway disorders due to inflammatory disordersYes
H47.521-529Visual pathway disorders due to neoplasmYes
H47.531-539Visual pathway disorders due to vascular disordersYes
H47.6Disorders of visual cortexNo
H47.611-619Cortical blindnessYes
H47.621-629Visual cortex disorders due to inflammatory disordersYes
H47.631-639Visual cortex disorders due to neoplasmYes
H47.641-649Visual cortex disorders due to vascular disordersYes
H47.9Unspecified disorder of visual pathwaysYes

Includes

The following clinical presentations and synonymous terms are appropriately captured by H47.10 when the underlying etiology of disc edema is not yet documented or confirmed:

  • Papilledema, not otherwise specified (NOS)
  • Optic disc edema, unspecified cause
  • Optic disc swelling, etiology undetermined
  • Choked disc (historical term for papilledema)
  • Bilateral disc swelling, cause unknown
  • Optic nerve head swelling, unspecified
  • Papilloedema (British spelling variant — same condition)
  • Disc elevation with blurred margins, etiology unspecified

Excludes

Excludes 1 (cannot be coded simultaneously — mutually exclusive)

Once a confirmed association or etiology is established, H47.10 must be replaced by the more specific code. H47.10 should not be reported alongside the following when the etiology is confirmed and documented:

Excluded ConditionCorrect Code
Papilledema associated with increased intracranial pressure (confirmed)H47.11
Papilledema associated with decreased ocular pressure (confirmed)H47.12
Papilledema associated with retinal disorder (confirmed)H47.13
Foster-Kennedy syndrome (confirmed)H47.141-H47.149
Pseudopapilledema / optic disc drusenH47.331-H47.339

Excludes 2 (may be reported together when both conditions are present and documented)

The following codes may appropriately accompany H47.10 when documented as separate, concurrent conditions or contributing comorbidities:

  • Intracranial hypertension codes (G93.2, G93.5) — when elevated ICP is confirmed, consider upgrading to H47.11 and coding the ICP condition separately; G93.2 and H47.11 are commonly reported together
  • Cerebral venous sinus thrombosis (I63.6, G08) — a cause of ICP-related papilledema
  • Space-occupying lesions / neoplasms (C71.x, D33.x) — when papilledema is a manifestation
  • Hypertensive crisis with optic disc changes (I10, I16.x) — hypertensive papillopathy
  • Optic neuritis (H46.0x) — distinct entity; papilledema and optic neuritis are different conditions but may coexist
  • Visual field defects (H53.4x) — may be documented as a complication of papilledema

Clinical Description & Pathophysiology

Definition

Papilledema is edema of the optic nerve head (disc) caused by increased pressure within the cerebrospinal fluid (CSF) surrounding the optic nerve sheath, transmitted from the intracranial compartment. It is classically bilateral and symmetric, though asymmetric presentation occurs. Unlike optic neuritis or ischemic optic neuropathy, true papilledema — in its early stages — typically preserves visual acuity, making it particularly dangerous because patients may be asymptomatic until permanent vision loss occurs.

Anatomical Basis

The optic nerve is surrounded by a dural sheath that is continuous with the meninges and communicates directly with the subarachnoid space. When intracranial pressure rises, that pressure is transmitted along the optic nerve sheath to the nerve head. This elevated pressure impedes axoplasmic flow within the retinal ganglion cell axons at the level of the lamina cribrosa, causing axonal swelling and disc edema. In chronic papilledema, this eventually leads to axonal loss and optic atrophy if left untreated.

Frisen Grading Scale (Clinical Staging)

Clinicians often grade papilledema severity using the Frisen scale, which has direct coding and documentation implications:

Frisen GradeClinical Findings
Grade 0Normal disc — no papilledema
Grade 1C-shaped halo of disc blurring, nasal margin obscured
Grade 2360° disc blurring, circumferential halo
Grade 3Blurring of major vessels leaving disc
Grade 4Complete blurring of vessels on disc, elevation of entire disc
Grade 5Dome-shaped protrusion of optic head, anterior segment compression

Note

Higher Frisen grades suggest more severe or chronic ICP elevation and are associated with greater risk of permanent visual field loss. Documentation of grade supports medical necessity for aggressive workup and treatment.

Common Underlying Etiologies Prompting Investigation

Elevated Intracranial Pressure (most common cause of true papilledema):

  • Idiopathic intracranial hypertension (IIH / pseudotumor cerebri) — G93.2; most common in obese women of childbearing age; associated with headache, pulsatile tinnitus, transient visual obscurations
  • Intracranial space-occupying lesion — primary or metastatic brain tumor, subdural hematoma, cerebral abscess
  • Cerebral venous sinus thrombosis — superior sagittal sinus or transverse sinus thrombosis; associated with hypercoagulable states, OCPs, dehydration
  • Hydrocephalus — obstructive or communicating; impairs CSF outflow or absorption
  • meningitis / encephalitis — inflammatory processes causing ICP elevation
  • Malignant hypertension / hypertensive encephalopathy
  • Dural arteriovenous fistula — high-flow shunting elevates venous and CSF pressure
  • Craniosynostosis (pediatric) — premature fusion impairs CSF dynamics
  • Medications — tetracyclines (minocycline, doxycycline), vitamin A/retinoids, growth hormone, anabolic steroids, corticosteroid withdrawal

Decreased Ocular Pressure (hypotony papilledema):

  • Post-surgical hypotony following glaucoma surgery, penetrating keratoplasty, or trauma
  • Wound leak or cyclodialysis cleft
  • Choroidal detachment with IOP collapse

Retinal Disorders:

  • Central retinal vein occlusion (CRVO) — can produce disc swelling mimicking papilledema
  • Diabetic papillopathy — disc swelling in diabetic patients, often mild and self-limiting
  • Hypertensive retinopathy — disc swelling as part of accelerated hypertension

Other / Systemic:

  • Anemia, polycythemia — hematologic causes of elevated ICP or vascular engorgement
  • Carbon dioxide retention (hypercapnia) — causes cerebral vasodilation and elevated ICP
  • Sleep apnea — recurrent hypercapnia as a cause of IIH
  • Lyme disease, sarcoidosis — granulomatous infiltration of meninges

Key Clinical Distinction: Papilledema vs. Pseudopapilledema

This distinction is critical for coding. Pseudopapilledema (H47.33x) mimics disc swelling but is not caused by elevated ICP. The most common cause is optic disc drusen — calcific deposits buried within the disc that elevate the disc surface and blur margins. Unlike true papilledema, pseudopapilledema does not carry the same urgency or risk. B-scan ultrasound demonstrating hyperechoic buried drusen is highly specific. OCT of the RNFL and fundus autofluorescence are also used. Once pseudopapilledema is confirmed, H47.33x replaces H47.10.

Symptoms & Clinical Presentation

  • Transient visual obscurations (TVOs) — brief, seconds-long episodes of graying or blackening of vision, often positional; highly characteristic of elevated ICP papilledema
  • Headache — typically worse in the morning, with Valsalva, or positional; often described as pressure-type
  • Pulsatile tinnitus — whooshing or rushing sound in the ears, often unilateral
  • Diplopia — due to sixth nerve palsy from increased ICP (false localizing sign)
  • Visual field loss — enlarged blind spot is earliest; later arcuate defects, then constriction; central acuity affected late
  • Nausea and vomiting — from ICP elevation
  • In early/mild cases: visual acuity may be entirely normal

HCC (Hierarchical Condition Category)

FieldDetail
HCC MappedNo
HCC CategoryH47.10 is not a CMS-HCC risk-adjusting diagnosis code
RxHCC MappedNo
Clinical Importance for HCCWhile H47.10 itself carries no HCC weight, the conditions that cause papilledema frequently do. Intracranial hypertension (G93.2) is not a standard HCC but neoplasms (C71.x), cerebral venous thrombosis (I63.6), and complications of hydrocephalus may carry significant DRG and risk-adjustment implications. Always code to the confirmed underlying etiology to maximize accurate risk capture.

MS-DRG Assignment

H47.10 as a principal or secondary diagnosis will typically route encounters to the following MS-DRGs:

MS-DRGTitleType
124Other Disorders of the Eye with MCCWith Major Complication or Comorbidity
125Other Disorders of the Eye without MCCWithout Major Complication or Comorbidity

CC/MCC Status: H47.10 functions as a CC (Complication or Comorbidity) when reported as a secondary diagnosis, meaning its presence alongside a principal diagnosis can shift an encounter from a lower-weighted DRG to the “with CC” variant, increasing the relative weight and associated reimbursement.

However, the encounter driving admission for papilledema workup is often neurologically focused. If the principal diagnosis is neurological (e.g., intracranial hypertension, cerebral venous thrombosis, or intracranial neoplasm), the MS-DRG will be governed by those codes rather than H47.10. In those cases, H47.10 (or more specifically H47.11) would function as a secondary diagnosis/CC.

Relevant alternate MS-DRGs when neurological etiology drives admission:

MS-DRGTitle
073Cranial and Peripheral Nerve Disorders with MCC
074Cranial and Peripheral Nerve Disorders without MCC
091-093Other Disorders of Nervous System
052-053Spinal Disorders & Injuries (if related)
054-055Nervous System Neoplasms

Tip

Always evaluate whether the neurological underlying cause should serve as principal diagnosis when papilledema is the presenting sign of a systemic or neurological disorder.


wRVU (Work RVU) — Professional Context

H47.10 is a diagnosis code and does not carry wRVUs directly. Work RVUs are attached to CPT procedure and evaluation codes. The following CPT codes and approximate wRVUs are commonly associated with the evaluation and management of papilledema:

Evaluation & Management

CPT CodeDescriptionwRVU (approx.)
99223Initial hospital care, high complexity3.86
99233Subsequent hospital care, high complexity2.00
99253Inpatient consultation, moderate complexity3.72
99255Inpatient consultation, high complexity5.41
99285Emergency department E&M, high complexity4.00

Ophthalmologic Examination

CPT CodeDescriptionwRVU (approx.)
92004Ophthalmological exam, new patient, comprehensive2.67
92014Ophthalmological exam, established, comprehensive1.97
92002Ophthalmological exam, new patient, intermediate1.43

Diagnostic Testing — Ophthalmic

CPT CodeDescriptionwRVU (approx.)
92083Visual field examination, extended (threshold)0.92
92081Visual field, limited0.45
92134OCT of retinal nerve fiber layer (RNFL)0.88
92133OCT of optic nerve0.88
92235Fundus photography with interpretation0.85
92240Indocyanine green angiography (ICG)1.30
92287Fundus photography, narrow-field, with interpretation0.85

Diagnostic Testing — Neurological / Procedural

CPT CodeDescriptionwRVU (approx.)
62270Lumbar puncture, diagnostic (opening pressure measurement)1.63
62272Lumbar puncture, therapeutic (CSF drainage for ICP)1.63
72141MRI brain without contrastTechnical only (radiology)
72147MRI brain with contrastTechnical only (radiology)
70553MRI brain with and without contrastTechnical only (radiology)
70547-70549MRA head (for venous sinus thrombosis)Technical only
70544MRA head without contrastTechnical only

Note

wRVUs listed are approximate and subject to annual CMS Physician Fee Schedule updates. Always verify against the applicable year’s PFS final rule.


Assistant Payable

H47.10 is a diagnosis code and does not directly govern assistant-at-surgery billing. However, for surgical procedures that may be performed as a result of the papilledema workup or treatment:

Optic Nerve Sheath Fenestration (ONSF):

  • CPT 67570 — Optic nerve decompression (orbital approach)
  • Assistant surgeon: Generally not payable by Medicare for this procedure unless medical necessity is documented for co-surgeon; verify individual MAC LCD and commercial payer policy
  • This is a specialized orbital procedure typically performed by an oculoplastic or neuro-ophthalmologist

Ventriculoperitoneal (VP) Shunt Placement:

  • CPT 62223 — Creation of shunt; ventriculoperitoneal
  • Assistant surgeon: Generally payable — indicator typically 1 or 2; verify per payer
  • VP shunting for refractory IIH-related papilledema is a multi-surgeon procedure often involving neurosurgery

Lumboperitoneal (LP) Shunt:

  • CPT 62351 / 62355 — Implantation/revision of spinal CSF shunt
  • Assistant payable: Verify per payer — typically not payable without additional documentation

Diagnostic Lumbar Puncture:

  • CPT 62270 — Not a surgical procedure; assistant not applicable

Present on Admission (POA) Reporting

FieldDetail
POA RequiredYes — for all inpatient admissions
Typical POAY in most inpatient scenarios — papilledema is typically the presenting finding driving admission
POA = N ScenarioIf papilledema develops or is newly identified during an inpatient stay for an unrelated condition (e.g., found incidentally during evaluation for another neurological event)
POA = WClinically undetermined — use when documentation supports that the condition may or may not have been present on admission
Coding NotePOA status is particularly important for papilledema when it develops in the setting of a hospital-acquired complication, such as shunt malfunction or medication side effect (e.g., tetracycline-associated IIH). Accurate POA reporting may affect quality metrics and potential HAC reporting.

Coding Guidelines & Sequencing

When to Use H47.10

Use H47.10 when:

  1. The provider documents papilledema (optic disc swelling, choked disc) and the underlying cause has not yet been determined or workup is still pending at the time of the encounter.
  2. The workup is completed and the provider does not identify or document a specific associated condition — the papilledema remains of unspecified etiology.
  3. Papilledema is the presenting finding driving the admission or encounter and no more specific code is yet warranted.

When NOT to Use H47.10

  • Do not use when a confirmed etiology is documented. Once intracranial hypertension is confirmed as the cause, use H47.11. Once a retinal cause is confirmed, use H47.13.
  • Do not use for pseudopapilledema or optic disc drusen — use H47.33x instead.
  • Do not use when the finding is confirmed to be optic neuritis (H46.0x) — a distinct inflammatory condition.
  • Do not use when the swelling is attributed to ischemic optic neuropathy (H47.01x) — elevated ICP is not the mechanism.
  • Do not confuse with optic atrophy (H47.2x) — atrophy is the end-stage sequela of chronic untreated papilledema, not the active disc swelling itself; both may potentially be coded when both are present in different eyes (e.g., Foster-Kennedy syndrome — H47.14x).

Sequencing Guidance

As Principal Diagnosis: H47.10 may serve as the principal diagnosis when papilledema is the reason for admission and no definitive underlying etiology has been established after workup. If the workup ultimately identifies a cause (e.g., IIH), the principal diagnosis should be reconsidered — the underlying condition should generally be principal with H47.11 as a secondary code.

As Secondary Diagnosis: H47.10 or the more specific papilledema codes are commonly sequenced as secondary when the principal diagnosis is the neurological or systemic condition causing the disc swelling.

Etiology/Manifestation Convention: When papilledema is a manifestation of an underlying systemic or neurological condition, the underlying condition is sequenced first per ICD-10-CM conventions. Example: IIH (G93.2) as principal → H47.11 as secondary (manifestation).

Combination Code Consideration: There is no combination code that captures both papilledema and IIH in a single code. Both must be reported separately.


Coding Examples

Example 1 — Emergency Presentation, Workup Pending

A 28-year-old obese woman presents to the emergency department with a 3-week history of daily headaches, pulsatile tinnitus, and two episodes of brief vision darkening in both eyes. Fundoscopic examination reveals bilateral disc swelling with blurred margins. MRI brain and MRV are ordered — results pending. Neurology and ophthalmology are consulted. No definitive etiology has been established at the time of the initial encounter.

Principal Dx: H47.10 — Unspecified papilledema Secondary Dx: E66.9 — Obesity, unspecified Secondary Dx: R51.9 — Headache, unspecified

Once IIH is confirmed and LP opening pressure is elevated (>25 cmH2O), revise to G93.2 (IIH) as principal and H47.11 as secondary.


Example 2 — Confirmed IIH with Papilledema

Patient admitted for management of confirmed idiopathic intracranial hypertension. LP shows opening pressure of 32 cmH2O. Fundoscopy confirms bilateral papilledema, Frisen Grade 3. Acetazolamide is initiated. Ophthalmology documents formal visual field testing showing bilateral enlarged blind spots.

Principal Dx: G93.2 — Benign intracranial hypertension (Idiopathic Intracranial Hypertension) Secondary Dx: H47.11 — Papilledema associated with increased intracranial pressure (H47.10 is replaced — specific association is confirmed) Secondary Dx: H53.409 — Unspecified visual field defects, unspecified eye (or specify laterally per documentation)


Example 3 — Papilledema from Cerebral Venous Sinus Thrombosis

A 34-year-old woman on oral contraceptives presents with 2 weeks of progressive headache and new bilateral disc swelling. MRV confirms superior sagittal sinus thrombosis. Hematology is consulted. Anticoagulation is initiated.

Principal Dx: I63.6 — Cerebral infarction due to cerebral venous thrombosis, nonpyogenic (alternatively G08 — Intracranial and intraspinal phlebitis and thrombophlebitis, if no infarction documented) Secondary Dx: H47.11 — Papilledema associated with increased intracranial pressure Secondary Dx: Z79.3 — Long-term use of hormonal contraceptives


Example 4 — Papilledema from Intracranial Neoplasm

A 55-year-old male with known non-small cell lung cancer presents with headache and bilateral disc swelling. MRI brain with contrast reveals two enhancing lesions in the right parietal and left frontal lobes consistent with metastatic disease. Neurosurgery is consulted.

Principal Dx: C79.31 — Secondary malignant neoplasm of brain Secondary Dx: C34.10 — Malignant neoplasm of upper lobe of bronchus or lung, unspecified (or specify per documentation) Secondary Dx: H47.11 — Papilledema associated with increased intracranial pressure (papilledema is the manifestation; the neoplasm drives the ICP elevation)


Example 5 — Medication-Induced IIH (Tetracycline)

A 19-year-old male on long-term minocycline for acne vulgaris presents with headache and incidentally discovered bilateral disc swelling during a routine eye exam. LP confirms elevated opening pressure. Minocycline is identified as the causative agent and discontinued.

Principal Dx: G93.2 — Benign intracranial hypertension Secondary Dx: H47.11 — Papilledema associated with increased intracranial pressure Secondary Dx: T36.4X5A — Adverse effect of tetracyclines, initial encounter (T-code for adverse effect of correctly prescribed and administered drug) Secondary Dx: L70.0 — Acne vulgaris (underlying condition being treated)


Example 6 — Foster-Kennedy Syndrome

A 63-year-old male presents with a large right-sided olfactory groove meningioma. Examination reveals right optic disc pallor (atrophy from direct compression of right optic nerve) and left disc swelling (papilledema from elevated ICP). This constellation is Foster-Kennedy syndrome.

Principal Dx: D32.0 — Benign neoplasm of cerebral meninges (or D35.2 for olfactory nerve if documented) Secondary Dx: H47.141 — Foster-Kennedy syndrome, right eye (atrophic disc) Secondary Dx: H47.142 — Foster-Kennedy syndrome, left eye (papilledema) (or H47.143 bilateral if both components are referenced together)


Example 7 — Papilledema vs. Pseudopapilledema

A 22-year-old female is referred for bilateral disc elevation. B-scan ultrasound reveals hyperechoic buried deposits at both disc heads. Fundus autofluorescence is positive. OCT shows no RNFL swelling consistent with axoplasmic stasis. LP is deferred. Diagnosis: optic disc drusen causing pseudopapilledema bilaterally.

Dx: H47.333 — Pseudopapilledema of optic disc, bilateral (H47.10 is NOT used — the entity is confirmed as pseudopapilledema, not true papilledema)


Clinical ScenarioCorrect Code
Papilledema, cause unspecifiedH47.10
Papilledema due to elevated ICP (confirmed)H47.11
Papilledema due to ocular hypotony (confirmed)H47.12
Papilledema due to retinal disorder (confirmed)H47.13
Foster-Kennedy syndrome, right eyeH47.141
Foster-Kennedy syndrome, left eyeH47.142
Foster-Kennedy syndrome, bilateralH47.143
Pseudopapilledema, bilateral (drusen)H47.333
Pseudopapilledema, right eyeH47.331
Pseudopapilledema, left eyeH47.332
Optic neuritis, right eyeH46.01
Optic neuritis, left eyeH46.02
NAION, right eyeH47.011
NAION, left eyeH47.012
Idiopathic intracranial hypertensionG93.2
Cerebral venous sinus thrombosisG08 / I63.6
Optic atrophy, bilateral (end-stage)H47.20 / H47.213
Visual field defect — enlarged blind spotH53.459 (other localized, or specify eye)
Sudden visual loss (if acute event)H53.131-H53.133
Papilloedema (alternate spelling)H47.10-H47.13 (same condition)

Documentation Tips for Providers

To support accurate and specific ICD-10-CM code selection, treating providers (ophthalmology, neurology, neurosurgery) should document:

  • Laterality — papilledema is typically bilateral, but confirm and document; asymmetric or unilateral disc swelling changes the differential
  • Frisen grade — document severity grade at each visit to support medical necessity and track progression or resolution
  • Confirmed etiology — once the cause is established, document it explicitly: “papilledema due to idiopathic intracranial hypertension” or “disc swelling in the setting of CSVT”
  • Distinction from pseudopapilledema — document the basis for ruling in true papilledema vs. drusen-related pseudopapilledema (ultrasound, OCT, FA findings)
  • Opening pressure — document LP opening pressure in cmH2O; required to confirm IIH diagnosis (>25 cmH2O with normal CSF composition)
  • Visual field findings — document formal Humphrey VF results and any progression; enlarged blind spot is the earliest field defect in papilledema
  • Medication history — document all medications including OTCs and supplements; tetracyclines, vitamin A, growth hormone, corticosteroid withdrawal are common culprits
  • Treatment plan — document whether medical management (acetazolamide, topiramate, weight loss), ONSF, or shunting is planned, to support procedural coding
  • POA context — note whether the disc swelling was identified on admission or discovered during the inpatient stay

Quick Reference Summary

FieldDetail
CodeH47.10
DescriptionUnspecified papilledema
Code TypeICD-10-CM Diagnosis
HIPAA ValidYes
ChapterVII — Diseases of the Eye and Adnexa
HCCNo
CC/MCC StatusCC (as secondary diagnosis)
MS-DRG124 (with MCC) / 125 (without MCC) — or neurological DRGs when etiology drives admission
POA RequiredYes
LateralityNot specified — papilledema is typically bilateral by nature
Upgrade When Etiology ConfirmedH47.11 (ICP), H47.12 (hypotony), H47.13 (retinal), H47.14x (Foster-Kennedy)
Do Not Confuse WithH47.33x (pseudopapilledema), H46.0x (optic neuritis), H47.01x (NAION)
Key Workup CodesLP (62270), OCT (92134), Visual field (92083), MRI brain (70553), MRV (70544)
Etiology/ManifestationWhen ICP cause is confirmed, underlying condition (e.g., G93.2) sequences first